Skip to main content

What the FDA labels say about taking them together

Bempedoic acid and pravastatin

Bempedoic acid's FDA label of June 25, 2026 names pravastatin in its drug interactions section; the pravastatin label PlainMeds reads does not name bempedoic acid. The bempedoic acid label: “Concomitant use of NEXLETOL with pravastatin causes an increase in pravastatin concentration and may increase the risk of pravastatin-related myopathy.”

Check it at the source: the bempedoic acid FDA label on DailyMed (effective June 25, 2026, Esperion Therapeutics, Inc.); the pravastatin FDA label on DailyMed (effective July 31, 2026, Apotex Corp.).

What does the bempedoic acid label say about pravastatin?

Bempedoic acid label, drug interactions

Pravastatin Clinical Impact: Concomitant use of NEXLETOL with pravastatin causes an increase in pravastatin concentration and may increase the risk of pravastatin-related myopathy. Intervention: Avoid concomitant use of NEXLETOL with pravastatin greater than 40 mg.

Source: FDA drug label (Nexletol), Esperion Therapeutics, Inc., effective June 25, 2026 (SPL set 88d06d89-a3da-40b4-b273-8f4f7d56c4c9), via openFDA; the full label on DailyMed

What does the pravastatin label say about bempedoic acid?

Pravastatin's label (effective July 31, 2026) does not name bempedoic acid in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PRAVASTATIN SODIUM), Apotex Corp., effective July 31, 2026 (SPL set dcf45e4f-b46e-6fbb-b67a-2ff619ab1780), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Bempedoic acid generic labelers
37Pravastatin generic labelers
Bempedoic acidPravastatin
Labeled forHeart attack and coronary artery disease, High cholesterolHeart attack and coronary artery disease, High cholesterol, High triglycerides
Boxed warningNoNo
Pharmacy cost (NADAC)$13.81 per tablet 180 mg tablet$0.058 per tablet 20 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?